Author:
Lu Zhen-Hai,Peng Jian-Hong,Wang Fu-Long,Yuan Yun-Fei,Jiang Wu,Li Yu-Hong,Wu Xiao-Jun,Chen Gong,Ding Pei-Rong,Li Li-Ren,Kong Ling-Heng,Lin Jun-Zhong,Zhang Rong-Xin,Wan De-Sen,Pan Zhi-Zhong
Publisher
Ovid Technologies (Wolters Kluwer Health)
Reference24 articles.
1. Cancer statistics, 2012;Siegel;CA Cancer J Clin,2012
2. Bevacizumab, capecitabine, and oxaliplatin as neoadjuvant therapy for patients with potentially curable metastatic colorectal cancer;Gruenberger;J Clin Oncol,2008
3. Surgical resection after downsizing of colorectal liver metastasis in the era of bevacizumab;Ellis;J Clin Oncol,2005
4. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer;Hurwitz;N Engl J Med,2004
5. Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study;Saltz;J Clin Oncol,2008
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献